Fabian Trillsch
Klinik für Frauenheilkunde(DE)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy, Endometriosis Research and Treatment, Estrogen and related hormone effects
Most-Cited Works
- → Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer(2016)262 cited
- → The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study(2013)135 cited
- → Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients(2015)127 cited
- → Clinical management of primary vulvar cancer(2011)97 cited
- → Management of borderline ovarian tumors(2016)97 cited
- → Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial(2024)94 cited